Article references (26 references )


  1. WHO. International Statistical Classification of Diseases and Related Health Problems 10th revision (ICD-10). WHO. 2010. cited 2016 Mar 11

  2. Steponavičienė L, Gudavičienė D, Meškauskas R. Rare types of breast carcinoma. Acta medica Litu. 2012;19(2):81-91. Google Scholar

  3. Acevedo C, Amaya C, López-Guerra J-L. Rare breast tumors: review of the literature. Reports Pract Oncol Radiother J Gt Cancer Cent Pozn Polish Soc Radiat Oncol. 2014;19(4):267-74. PubMed | Google Scholar

  4. Rapin V, Contesso G, Mouriesse H, Bertin F, Lacombe MJ, Piekarski JD et al. Medullary breast carcinoma: a reevaluation of 95 cases of breast cancer with inflammatory stroma. Cancer. 1988; 61(12):2503-10. PubMed | Google Scholar

  5. Yerushalmi R, Hayes MM, Gelmon KA. Breast carcinoma-rare types: review of the literature. Ann Oncol. 2009; 20(11):1763-70. PubMed | Google Scholar

  6. Gudaviciene D, Steponaviciene L, Meskauskas R, Smailyte G, Aleknavicius E. Rare types of breast carcinoma. Open Med. 2014; 10(1):9-14. PubMed | Google Scholar

  7. Louwman MWJ, Vriezen M, van Beek MWPM, Nolthenius-Puylaert MCBJET, van der Sangen MJC, Roumen RM et al. Uncommon breast tumors in perspective: incidence, treatment and survival in the Netherlands. Int J cancer. 2007; 121(1):127-35. Google Scholar

  8. Liu J, Yu Y, Sun J, He S, Wang X, Yin J et al. Clinicopathologic characteristics and prognosis of primary squamous cell carcinoma of the breast. Breast Cancer Res Treat. 2015; 149(1):133-40. PubMed | Google Scholar

  9. Pedersen L, Zedeler K, Holck S, Schiřdt T, Mouridsen HT. Medullary carcinoma of the breast: prevalence and prognostic importance of classical risk factors in breast cancer. Eur J Cancer. 1995; 31A(13-14):2289-95. PubMed | Google Scholar

  10. Makki J. Diversity of Breast Carcinoma: histological Subtypes and Clinical Relevance. Clin Med Insights Pathol. 2015;8:23-31. PubMed | Google Scholar

  11. Huo D, Hu H, Rhie SK, Gamazon ER, Cherniack AD, Liu J et al. Comparison of breast cancer molecular features and survival by african and european ancestry in the cancer genome Atlas. JAMA Oncol. 2017; 3(12):1654-62. PubMed | Google Scholar

  12. Ibrahim NA, Oludara MA. Socio-demographic factors and reasons associated with delay in breast cancer presentation: a study in Nigerian women. Breast. 2012; 21(3):416-8. PubMed | Google Scholar

  13. Elumelu TN, Adenipekun AA, Abdus-salam AA, Bojude AD. Pattern of breast cancer metastasis at the radiotherapy clinic, Ibadan: a ten year review. J Am Sci. 2011; 7(7):906-12. Google Scholar

  14. Ketiku K. The pattern of metastases in Nigerian breast cancer patients. Clin Radiol. 1986; 37(6):563-5. PubMed | Google Scholar

  15. Campbell O, Agwimah R, Oduola B. Radiotherapy management of breast cancer in 400 Nigerians. Niger Med J. 1998; 27:27-35.

  16. Popoola A, Ogunleye O, Ibrahim N, Omodele FIA. Five year survival of patients with breast cancer at the Lagos State University Teaching Hospital, Nigeria. Online J Med Med Sci Res. 2012; 1(2):24-31.

  17. Dieci MV, Orvieto E, Dominici M, Conte P, Guarneri V. Rare breast cancer subtypes: histological, molecular, and clinical peculiarities. Oncologist. 2014; 19(8):805-13. PubMed | Google Scholar

  18. Nagao T, Kinoshita T, Hojo T, Tsuda H, Tamura K, Fujiwara Y. The differences in the histological types of breast cancer and the response to neoadjuvant chemotherapy: the relationship between the outcome and the clinicopathological characteristics. Breast. 2012; 21(3):289-95. PubMed | Google Scholar

  19. Kene TS, Odigie VI, Yusufu LM, Yusuf BO, Shehu SM, Kase JT. Pattern of presentation and survival of breast cancer in a teaching hospital in north Western Nigeria. Oman Med J. 2010; 25(2):104-7. PubMed | Google Scholar

  20. Anyanwu SN. Survival following treatment of primary breast cancer in eastern Nigeria. East Afr Med J. 2000; 77(10):539-43. PubMed | Google Scholar

  21. Di Saverio S, Gutierrez J, Avisar E. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma. Breast Cancer Res Treat. 2008; 111(3):541-7. PubMed | Google Scholar

  22. Vu-Nishino H, Tavassoli FA, Ahrens WA, Haffty BG. Clinicopathologic features and long-term outcome of patients with medullary breast carcinoma managed with breast-conserving therapy (BCT). Int J Radiat Oncol Biol Phys. 2005; 62(4):1040-7. PubMed | Google Scholar

  23. Thurman SA, Schnitt SJ, Connolly JL, Gelman R, Silver B, Harris JR et al. Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma. Int J Radiat Oncol Biol Phys. 2004; 59(1):152-9. PubMed | Google Scholar

  24. Hennessy BT, Krishnamurthy S, Giordano S, Buchholz TA, Kau SW, Duan Z et al. Squamous cell carcinoma of the breast. J Clin Oncol. 2005; 23(31):7827-35. Google Scholar

  25. Kothari AS, Beechey-Newman N, Hamed H, Fentiman IS, D'Arrigo C, Hanby AM et al. Paget disease of the nipple: a multifocal manifestation of higher-risk disease. Cancer. 2002; 95(1):1-7. PubMed | Google Scholar

  26. Memis A, Ozdemir N, Parildar M, Ustun EE, Erhan Y. Mucinous (colloid) breast cancer: mammographic and US features with histologic correlation. Eur J Radiol. 2000; 35(1):39-43. PubMed | Google Scholar